Sharemaestro Newsreel

Check-Cap Ltd. (NASDAQ: MBAI) expands MBody AI into outdoor robot services

Check-Cap Ltd. announced that its merger partner, MBody AI Corp., is expanding its autonomous services from indoor to outdoor applications. MBody AI has secured exclusive U.S. distribution rights for outdoor cleaning robots across six states for gaming and large hotel operators and has already …

ICON plc (NASDAQ: ICLR) prices $2.15B notes to refinance secured debt

ICON plc announced the pricing of $2.15 billion in senior unsecured notes through its subsidiary, ICON Investments Six DAC, to refinance existing secured debt. The offering, consisting of three tranches due in 2029, 2031, and 2036, is expected to close on August 13, 2026. …

CareDx, Inc. (CDNA) director sells 16,000 shares in planned trade

CareDx, Inc. director Christine Cournoyer sold 16,000 shares of common stock on August 4, 2026, under a Rule 10b5-1 trading plan. The shares were sold at a weighted average price of $46.9358 per share, ranging from $46.25 to $47.2250, leaving her with 42,943 shares. …

THERMO FISHER SCIENTIFIC INC. SEC Filing (Aug 6, 2026)

This article reports on an SEC Form 144 filing by Thermo Fisher Scientific Inc. (TMO) on August 6, 2026. The filing indicates a proposed sale of 5,850 shares of common stock acquired through a stock option exercise, with an aggregate market value of $3,393,000.00. …

Danaher Corp (NYSE: DHR) awards 15,402 RSUs to EVP Gregory Milosevich

Danaher Corporation granted 15,402 restricted stock units (RSUs) to Executive Vice President Gregory M. Milosevich on August 4, 2026, as part of its Long-Term Growth Plan. These RSUs will vest 100% on the 24-month anniversary of the grant date. Following this award, Milosevich directly …

Charles River Laboratories , Inc. Stock 12‑Month Price Target Raised to $277.92, Implies 7% Upside

Analysts have raised the 12-month average price target for Charles River Laboratories International, Inc. (CRL) stock from $274.85 to $277.92, indicating a 7% potential upside from its August 5th closing price. The consensus rating among 19 analysts remains "Buy," with 14 recommendations for Buy, …

Charles River Labs (CRL) CEVP sells 5,046 shares under 10b5-1 plan

Shannon M. Parisotto, CEVP of Discovery & Safety Assessment at Charles River Laboratories International, Inc. (CRL), sold 5,046 shares of common stock at $263.00 per share on August 5, 2026. This transaction was conducted under a Rule 10b5-1 Trading Plan established on March 4, …

Sotera Health Co 2026: Revenue $321.38M, EPS $0.19— 10-Q Summary

Sotera Health Co (SHC) reported strong second-quarter 2026 results, with revenue reaching $321.38 million and diluted EPS of $0.19. The company saw significant year-over-year improvement across all key financial metrics, driven by higher service pricing and a favorable product mix. Despite ongoing expenses related …

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. SEC Filing (Aug 6, 2026)

This article details an SEC Form 144 filing by CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) on August 6, 2026. The filing indicates a proposed sale of 4,179 shares of common stock acquired through a stock option exercise, with an aggregate market value of $1,086,540, …

Charles River Laboratories International Q2 Earnings Call Highlights

Charles River Laboratories International (CRL) exceeded Q2 expectations, driven by improved demand in its Discovery and Safety Assessment (DSA) business and strong manufacturing performance. The company raised its full-year guidance for revenue, earnings, and free cash flow, anticipating a gradual recovery in biopharmaceutical demand. …

Check-Cap Ltd. (MBAI) stock price, news, quote and history

This page provides comprehensive information on Check-Cap Ltd. (MBAI) stock, including its current price, historical data, key statistics, and recent news. The company, a clinical-stage medical diagnostics firm based in Israel, specializes in capsule-based screening technology for colorectal polyps and is currently involved in …

Adaptive Biotechnologies (ADPT) Stock Gains Little As MRD Growth Meets Wider Losses

Medpace Holdings, Inc. $MEDP Shares Sold by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company reduced its stake in Medpace Holdings, Inc. ($MEDP) by 12.5% in the first quarter, selling 2,063 shares. Despite this, Medpace reported strong quarterly results with higher-than-expected EPS and revenue, and issued positive fiscal 2026 EPS guidance. The stock opened …

Illumina Inc. stock underperforms Thursday when compared to competitors

Illumina Inc. (ILMN) stock dropped 3.08% on Thursday, closing at $193.72, underperforming the broader market. This marks the second consecutive day of losses for the stock, as the S&P 500 Index and Dow Jones Industrial Average also saw declines.

Thermo Fisher Stock Clawed Back From a 31% Slide. A Guidance Raise May Explain Why.

Thermo Fisher Scientific (TMO) experienced a significant reacceleration in demand across its end markets, leading to a 5% organic revenue growth in Q2, two points above guidance. This strong performance allowed the company to raise its full-year adjusted EPS guidance. The stock, which had …

Quest Diagnostics Inc. stock outperforms competitors on strong trading day

Shares of Quest Diagnostics Inc. rose 1.13% to $238.50 on a strong trading day, outperforming the S&P 500 Index and the Dow Jones Industrial Average, both of which experienced declines. This marks the third consecutive day of gains for the stock.

Qiagen N.V. : Jefferies reiterates its Buy rating

Jefferies has reiterated its "Buy" rating for Qiagen N.V., reflecting a positive outlook on the stock. This comes as Qiagen's Q2 earnings exceeded expectations, though the company has maintained its guidance, similar to its peers. The article also provides a brief company profile, financial …

J.P. Morgan Maintains Icon PLC(ICLR.US) With Hold Rating, Raises Target Price to $165

J.P. Morgan has reiterated its "Hold" rating for Icon PLC (ICLR.US) and increased the target price to $165. This indicates a continued cautious but not bearish outlook on the company's stock by the financial institution. The raised target price suggests a slightly improved valuation …

Agilent Premieres 1290 Infinity III Fluorescence Detector

Agilent Technologies Inc. has launched the Agilent 1290 Infinity III Fluorescence Detector (FLD), designed to extend fluorescence detection capabilities into modern ultra-high-performance liquid chromatography (UHPLC) workflows. This new detector offers ultra-trace sensitivity, UHPLC-ready chromatographic performance, and ease of use, making it suitable for standalone …

Qiagen NV (0RLT) Q4 2024 Earnings Report - Results, Call & Slides

Qiagen NV (0RLT) reported its Q4 2024 earnings, with an actual EPS of €0.56 matching the consensus but missing by less than €0.01 against expectations. The company's revenue for Q4 2024 was €452.34M, slightly beating the expected €452.21M. Qiagen also provided details for its …

Bronstein, Gewirtz & Grossman, LLC Encourages Myriad Genetics, Inc. (MYGN) Investors to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential securities claims against Myriad Genetics, Inc. (MYGN) after the company reported significantly lower-than-expected Q2 2026 revenue and drastically cut its full-year 2026 guidance. This announcement followed Myriad Genetics reiterating stronger guidance just three months prior, leading …

FMR LLC discloses 7.6% Twist Bioscience (TWST) holding in new ownership filing

FMR LLC has filed a Schedule 13G, disclosing a beneficial ownership of 7.6% in Twist Bioscience Corp (TWST) as of June 30, 2026. This translates to 4,703,044.11 shares, with FMR LLC holding sole dispositive power over all these shares and sole voting power over …

Veracyte Inc (VCYT) Earnings Forecast: Future EPS & Revenue Growth Estimates

Veracyte Inc (VCYT) has an earnings forecast score of 8.46, ranking 126th in the Biotechnology & Medical Research industry. Analysts have set an average price target of $48.00, with a consensus "Buy" rating based on 13 analysts. The company's expected revenue for the next …

Will Thermo Fisher's (TMO) New EXENT Myeloma Platform and Q2 Results Shift Its Diagnostics Narrative?

Thermo Fisher Scientific recently announced strong Q2 2026 results with US$11.99 billion in sales and US$1.74 billion in net income, alongside new diagnostic product launches and FDA clearances, including the EXENT multiple myeloma platform. While these developments reinforce the company's innovation narrative and could …

WATERS CORP /DE/ SEC Filing (Aug 6, 2026)

This article details a Form 144 SEC filing by WATERS CORP /DE/ (WAT) on August 6, 2026. The filing indicates a proposed sale of securities, specifically 3626 shares of common stock with an aggregate market value of $1,442,930.44, acquired through a stock option exercise. …

FMR LLC reports 8.8% ownership of Charles River (CRL) common stock

FMR LLC has disclosed an 8.8% beneficial ownership stake in Charles River Laboratories International, Inc. (CRL) common stock as of June 30, 2026. This translates to 4,239,751.47 shares, with FMR LLC exercising sole voting power over 4,190,715.80 shares and sole dispositive power over all …

Is Sotera Health Co (SHC) Overvalued After Q2 Earnings Beat? EPS at $0.19 vs. Est. $0.17; Revenue at $321.4M

CareDx, Inc. SEC Filing (Aug 5, 2026)

This article details a CareDx, Inc. (CDNA) SEC Filing on Form 144, dated August 5, 2026. The filing indicates a proposed sale of 20,000 shares of common stock by an individual who acquired them as compensation for past services in 2015, with an aggregate …

Will Sotera Health's (SHC) Sharp Profit Rebound and Higher EPS Rewrite Its Turnaround Narrative?

Sotera Health (SHC) reported a significant profit rebound in Q2 2026, with net income rising to US$53.64 million and EPS to US$0.19, shifting from a net loss in the first half of the year. This turnaround in profitability is a key catalyst for its …

Sotera Health (NASDAQ:SHC) Beats Q2 Estimates and Raises Guidance, But Shares Slip

Sotera Health (SHC) exceeded analyst expectations for its second-quarter earnings and revenue, reporting $0.26 adjusted EPS and $321.4 million in net revenues. The company also raised its full-year guidance for net revenues and adjusted EPS, and improved its net leverage to 3.0 times. Despite …

Qiagen N.V. 2026 Q2 - Results - Earnings Call Presentation (NYSE:QGEN) 2026-08-06

Check-Cap: MBody AI Takes Autonomous Services Outdoors, Expanding Addressable Market

Check-Cap (NASDAQ: MBAI) announced that MBody AI, with which it plans to merge, has expanded its addressable market by securing exclusive U.S. distribution rights for outdoor cleaning robots in gaming and hospitality across six states. This move allows MBody AI to automate services outdoors …

Sotera Health Company (SHC) Beats Q2 Earnings and Revenue Estimates

Sotera Health Company (SHC) reported strong Q2 2026 earnings, beating analyst estimates for both EPS ($0.26 vs. $0.24) and revenue ($321.38 million vs. $310.27 million). This marks the fourth consecutive quarter the company has surpassed both earnings and revenue expectations. Despite this positive performance, …

Sotera Health Company (NASDAQ:SHC) Surprises With Strong Q2 CY2026

Sotera Health (NASDAQ:SHC) reported strong Q2 CY2026 results, exceeding revenue and adjusted EPS expectations with sales up 9.2% year-on-year to $321.4 million. The company slightly increased its full-year revenue and Adjusted EPS guidance, demonstrating focused execution across its business units. Despite a mediocre 6.7% …

Dimensional Fund Advisors LP Sells 104,038 Shares of Castle Biosciences, Inc. $CSTL

Dimensional Fund Advisors LP reduced its stake in Castle Biosciences (NASDAQ:CSTL) by 9.1%, selling 104,038 shares but still retaining over 1 million shares valued at approximately $25.5 million. This comes as Castle Biosciences exceeded Q1 revenue and EPS expectations, reporting $99.86 million in revenue …

Labcorp EVP Amy Summy sells $283k in common stock

Labcorp Executive Vice President Amy Summy sold 924 shares of company common stock for $283,427 on August 4, 2026, at a price of $306.74 per share. Following this transaction, she directly holds 6,955.50 shares. This news follows Labcorp's strong second-quarter results, where adjusted EPS …